Connect Biopharma Holdings Limited (CNTB)

NASDAQ: CNTB · IEX Real-Time Price · USD
+0.054 (7.27%)
Sep 29, 2023, 10:19 AM EDT - Market open

Total Valuation

CNTB has a market cap or net worth of $44.06 million. The enterprise value is -$88.58 million.

Market Cap 44.06M
Enterprise Value -88.58M

Important Dates

The last earnings date was Tuesday, September 12, 2023, after market close.

Earnings Date Sep 12, 2023
Ex-Dividend Date n/a

Share Statistics

CNTB has 55.07 million shares outstanding.

Shares Outstanding 55.07M
Owned by Insiders (%) 39.86%
Owned by Institutions (%) 39.87%
Float 18.45M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.32
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.26, with a Debt / Equity ratio of 0.00.

Current Ratio 9.26
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3,834.35

Financial Efficiency

Return on equity (ROE) is -51.50% and return on invested capital (ROIC) is -144.50%.

Return on Equity (ROE) -51.50%
Return on Assets (ROA) -46.50%
Return on Capital (ROIC) -144.50%
Revenue Per Employee n/a
Profits Per Employee -$839,412
Employee Count 100
Asset Turnover n/a
Inventory Turnover n/a


In the past 12 months, CNTB has paid $239,609 in taxes.

Income Tax 239,609
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -38.36% in the last 52 weeks. The beta is -0.45, so CNTB's price volatility has been lower than the market average.

Beta (1Y) -0.45
52-Week Price Change -38.36%
50-Day Moving Average 0.86
200-Day Moving Average 1.02
Relative Strength Index (RSI) 46.29
Average Volume (30 Days) 31,219

Short Selling Information

Short Interest 7,490
Short Previous Month 8,671
Short % of Shares Out 6.58%
Short % of Float n/a
Short Ratio (days to cover) 0.82

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -85.91M
Pretax Income -83.02M
Net Income -83.94M
EBIT -83.00M
Earnings Per Share (EPS) -$1.52
Full Income Statement

Balance Sheet

The company has $130.24 million in cash and $588,268 in debt, giving a net cash position of $129.65 million or $2.35 per share.

Cash & Cash Equivalents 130.24M
Total Debt 588,268
Net Cash 129.65M
Net Cash Per Share $2.35
Equity / Book Value 127.37M
Book Value Per Share 2.31
Working Capital 122.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$76.81 million and capital expenditures -$2.74 million, giving a free cash flow of -$79.56 million.

Operating Cash Flow -76.81M
Capital Expenditures -2.74M
Free Cash Flow -79.56M
FCF Per Share -$1.45
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -204.37%
FCF Yield -193.70%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -2.04%
Shareholder Yield -2.04%

Analyst Forecast

The average price target for CNTB is $6.00, which is 650.00% higher than the current price. The consensus rating is "Buy".

Price Target $6.00
Price Target Difference 650.00%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a